Vivanza Biosciences files a regulatory compliance letter with BSE Limited regarding fundraising disclosure requirements.
The company confirms it has not raised any funds through public issues, rights issues, or preferential issues during the period.
Consequently, the statement of deviation or variation under SEBI Regulation 32 is not applicable to the company.